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The general transcription factor TFIID is a largemulti-
subunit complex required for the transcription of
most protein-encoding genes by RNA polymerase
II. Taking advantage of a TFIID preparation partially
depleted in the initiator-binding Taf2p subunit, we
determined the conformational and biochemical vari-
ations of the complex by electron tomography and
cryo-electronmicroscopy of singlemolecules. Image
analysis revealed the extent of conformational flexi-
bility of the complex and the selection of the most
homogeneous TFIID subpopulation allowed us to
determine an improved structural model at 23A˚ reso-
lution. This study also identified two subpopulations
of Taf2p-containing and Taf2p-depleted TFIID mole-
cules. By comparing these two TFIID species we
could infer the position of Taf2p, which was con-
firmed by immunolabeling using a subunit-specific
antibody.Mapping the position of this crucial subunit
in the vicinity of Taf1p and of TBP sheds new light on
its role in promoter recognition.
INTRODUCTION
The general transcription factor TFIID is a multisubunit protein
required for the initiation of eukaryotic DNA transcription
by RNA polymerase II (Pol II). In the yeast Saccharomyces
cerevisiae, TFIID is essential for both cell viability and ongoing
high-level mRNA gene transcription. Consistent with these
observations, genome-wide chromatin immunoprecipitation
location analyses (ChIP-chip) have demonstrated that in vivo
TFIID is resident on most active mRNA gene promoters (Zanton
and Pugh, 2006). Similarly in higher eukaryotes, the null alleles
of TFIID components lead to lethality through early embryogen-
esis defects (Mohan et al., 2003). ChIP-chip studies performed
with human cells have shown that 90% of scored mRNA
gene promoters were occupied by TFIID (Kim et al., 2005).
Thus TFIID is utilized extensively for Pol-II-mediated mRNA
gene transcription.
TFIID is composed of the TATA box binding protein (TBP) and
14 TBP-associated factors (Tafs) whose sequences areStructure 17,conserved from yeast to humans (Burley and Roeder, 1996). In
a reconstituted in vitro system, TBP by itself can direct the
formation of a transcriptional preinitiation complex (PIC) when
combined with the five general transcription factors (GTFs) TFIIA,
TFIIB, TFIIE, TFIIF, and TFIIH, and will support RNA polymerase II
initiation from a TATA-box-containing promoter (Hampsey and
Reinberg, 1999). However, this basal transcription system fails
to respond to activators, and only poorly transcribes genes
that do not contain TATA elements (Juven-Gershon et al.,
2008). Recent experiments demonstrate crosstalk between
modified nucleosomes and mammalian TFIID through an inter-
action between the PHD finger of Taf3p and trimethylated
histone H3 at lysine 4 (Vermeulen et al., 2007). Although an
explicit role for TFIID in histone acetylation lacks direct in vivo
evidence, the histone acetyl transferase domain of Taf1p is
capable of acetylating the N termini of free or nucleosomal
histones (Mizzen et al., 1996). Numerous reports, using various
in vivo contexts and readouts, have documented that several
Tafs, in particular Taf4p and Taf12p, contribute to transcriptional
activation (Hamard et al., 2005; Mengus et al., 1997; Taatjes
et al., 2004; Voulgari et al., 2008). A direct interaction was
documented in S. cerevisiae between the transcription transac-
tivator Rap1p and the Taf4p, 5p, and 12p components of highly
purified TFIID (Garbett et al., 2007). These findings identify TFIID
as a major transcriptional coactivator that can respond to several
distinct biological pathways.
Tafs have been shown to assist TBP in promoter DNA binding,
showing that TFIID is a core promoter recognition complex (Lee
et al., 2005; Martinez et al., 1994). Taf1p and Taf2p can form
a subcomplex with TBP that specifically binds to promoter
DNA in vitro (Chalkley and Verrijzer, 1999). The Taf2p subunit
was shown to interact specifically with the initiator (Inr) element
found at the transcription start site of many genes (Oelgeschl-
ager et al., 1996; Purnell et al., 1994; Sypes and Gilmour, 1994;
Verrijzer et al., 1994). For these reasons, it has been hypothe-
sized that Taf2p-Inr interactions play a key role in both promoter
binding and start-site selection (Hansen and Tjian, 1995).
The studies described in this report were aimed at elucidating
the location of Taf2p within the yeast TFIID (yTFIID) complex.
Taf2p is the only integral TFIID subunit whose location within
the complex has yet to be determined (Leurent et al., 2004). Given
the large size (Mr = 161 kDa) and key functionalities of Taf2p in
promoter recognition noted above, there is a clear need to map
the location of this subunit in the TFIID holocomplex. The363–373, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 363
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Mapping Taf2p within TFIIDFigure 1. Heterogeneity in Taf2p Content in TFIID Purified by Different Methods
(A) Sypro Ruby stained SDS-PAGE gel showing the subunit content of either HA-tagged Taf1p (HA) or TAP-tagged Taf1p (two independent preparations, TAP-A
and TAP-B) purified TFIID. Molecular weight standards were run in parallel (MW) and the TFIID subunits are labeled. The stained gel was scanned (BioRad FX
imager) and Taf1p and Taf2p content was determined using QuantityOne software (BioRad).
(B) Apparent dissociation of a portion of Taf2p from the TFIID holocomplex during Mono-S FPLC. CaM-Sepharose eluted TAP-TFIID was subjected to Mono-S
FPLC and eluted with 1 M NaCl as shown. The protein composition of the fractionated TFIID was measured by SDS-PAGE as in (A), and fraction number, molec-
ular weight standards (MW), input to Mono-S column (In), and unbound proteins (BT) indicated. The Taf2p and Taf1p subunits in the Mono-S 1 M salt-eluted
fractions are indicated by asterisks.complexity of TFIID has prevented structure determination by
X-ray crystallography, and thus far electron microscopy (EM)
has provided the only available structural models (Andel et al.,
1999; Brand et al., 1999). Image analysis of isolated yTFIID mole-
cules revealed a 3D model at 32 A˚ resolution (Leurent et al., 2002).
Human TFIID (hTFIID) was recently investigated in cryo-EM, but
the resolution was not dramatically improved over that obtained
for yTFIID (Grob et al., 2006). The authors described considerable
conformational flexibility within hTFIID, which is a major limitation
for high-resolution structural determination.
In the present work, the structural variability of a TFIID prepa-
ration partially depleted in Taf2p was studied. This analysis
allowed us to discriminate between two major contributions to
structural variations: the conformational flexibility of the TFIID
molecule and the lack of Taf2p. An additional domain was
identified in some yTFIID molecules, and immunolabeling
demonstrated that this domain mapped to the N-terminal portion
of Taf2p. The N terminus of Taf2p bears sequence homology
with the M1 family of metallopeptidases (Callebaut et al., 2005)
whose atomic structure has been solved. This homology domain
could be fitted into the additional density generated by Taf2p.
The Taf2p content thus appears as a major source of specimen
heterogeneity and the selection of a homogeneous Taf2p-con-
taining TFIID subpopulation allowed us to significantly improve
the resolution of the TFIID model to 23 A˚.364 Structure 17, 363–373, March 11, 2009 ª2009 Elsevier Ltd All riRESULTS
Taf2p Heterogeneity in TFIID Prepared
by Different Procedures
During the course of pilot experiments to explore alternative
purification strategies for yTFIID, we observed large variations
in the stoichiometry of the Taf2p subunit relative to our standard
TFIID preparation. Our standard TFIID purification method used
a yeast strain expressing an N-terminally HA1-tagged Taf1p and
involved Bio-Rex 70, anti-HA monoclonal antibody, and Mono-S
fast protein liquid chromatography (FPLC) (Sanders et al., 2002;
Sanders and Weil, 2000). To investigate the use of the tandem
affinity purification (TAP) method for TFIID purification, we
utilized a yeast strain expressing C-terminally TAP-tagged
Taf1p (Rigaut et al., 1999). The TAP method was optimized for
TFIID solubilization and overall yield. We often observed reduced
amounts of Taf2p relative to Taf1p in the TAP-purified TFIID (see
Sypro Ruby stained SDS-PAGE, Figure 1A). Quantitation of the
amounts of these two Tafs in the various preparations confirmed
this observation; the Taf2p/Taf1p content of HA-TFIID was 0.7
compared with TAP-TFIID preparations A (Taf2/Taf1p = 0.1)
and B (Taf2/Taf1p = 0.4). It is likely that Taf2p is preferentially
lost from the TFIID complex. Such loss of the full-length Taf2p
subunit was observed previously by Smale and colleagues,
who have reported that human Taf2p, which they termed CIF,ghts reserved
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Mapping Taf2p within TFIIDreadily dissociates from hTFIID (Kaufmann et al., 1996). We have
observed a similar phenomenon; a fraction of yeast Taf2p disso-
ciated from yTFIID during ion exchange chromatography,
perhaps in association with other TFIID subunits (Figure 1B;
compare Taf2p/Taf1p amounts (asterisks) in the Mono-S Input
[In] versus amounts in gradient fractions, 4, 5–10). Together
these results suggest that complete loss of the Taf2p subunit
is the most likely explanation for the reduced stoichiometry of
this subunit in the case of the TAP-purified TFIID. The different
TFIID preparations were found to contain negligible amounts of
DNA (Figure S1), indicating that variable DNA content does not
introduce additional variations.
Single-Particle Tomography
We decided to use the observed Taf2p subunit deficiency to our
advantage given that otherwise the TFIID subunit composition
of the TAP-TFIID was normal (cf. Figure 1A). We reasoned that
image analysis of the TFIID preparation partially depleted in
Taf2p should reveal different particle populations and identify
the location of the subunit within the holocomplex. The TAP-
A-TFIID preparation is likely to contain two major forms of struc-
tural variation: biochemical differences in Taf2p content and
conformational changes. Standard image analysis of molecular
views is unable to resolve such complex variation because most
views cannot be unambiguously attributed to a given species.
Consequently we used electron tomography of single particles
to experimentally reveal these different TFIID populations. This
method generates a low-resolution 3D model for each individual
particle. A total of 157 individual molecular volumes were recon-
structed from a field of negatively stained TAP-A-TFIID mole-
cules. These volumes were aligned one with respect to the
others using a combination of interactive and correlation-based
methods (Figure S2). The aligned volumes were classified into
28 groups according to maximal interclass resemblance and
an average volume was calculated for each class. As a conse-
quence of the limited resolution (estimated to be 50 A˚ on
average) only large 3D variations could be detected
(Figure 2A). In general the volumes showed a three-lobed orga-
nization as reported previously, although 4 of the 28 volumes
apparently lacked one lobe, and the relative size of the lobes
was found to be highly variable. The enclosed angle between
the three lobes and the distance between the centers of the
external lobes A and B also showed large variations. In the
most closed conformation the distance between the lobes is
100 A˚ and the enclosed angle is 53, whereas in the most
open conformation the distance between lobe A and B is 220
A˚ and the enclosed angle is 115.
The volumes obtained by electron tomography of single mole-
cules provide a repertoire of the most extreme conformations
that can be found in the TAP-A-TFIID preparation. The observed
variability is likely to reflect the full range of conformational space
as well as the biochemical variations of the data set plus any
possible structural perturbations introduced by the preparation
method.
Analysis of the TFIID Structural Variants in Negatively
Stained, Frozen Hydrated Samples
In order to reveal greater structural detail, and to improve the
statistical significance of the tomography volumes, we analyzedStructure 17,a large image dataset of 44,233 single particles for which two
parameters were modified to reduce preparation-induced spec-
imen variability (Figure S3). First the TFIID molecules were
observed under negative stain (NS) cryo-EM conditions in order
to preserve the hydrated structure of the particle (Golas et al.,
2005). Second the molecules were chemically cross-linked ac-
cording to the GraFix method (Kastner et al., 2008) in order to
lock the complex in a reduced number of conformational states.
The tomographic volumes were utilized to sort the particle
images into different categories and to verify which structural
variants were present. Among the 28 average tomographic
volumes, only 6 were used extensively because 75% of the
images aligned with highest correlation against references is-
sued from these volumes. The remaining 22 volumes were
each used by less than 5% of the images and were discarded
from further analysis. Upon refinement two of the six models
were progressively less used and were discarded once they at-
tracted less than 5% of the images. Four stable TFIID popula-
tions were thus identified, and a 3D model was reconstituted
for each (Figure 2B). These results suggest that dehydration is
likely to be the source of a large part of the variation found in
the tomographic volumes, and that only a limited fraction of
the particles adopt the most extreme conformations after chem-
ical cross-linking.
The four remaining models are organized as a molecular
clamp formed by three or four successive lobes (A, B, C1, and
C2), but differ significantly in the relative position of the lobes
because the distance between the centers of the external lobes
varied from 140 A˚ to 159 A˚. When the same intensity threshold is
set to all models, model 4 was found to be larger than the three
other models. Models 1, 2, and 3 comprise an average volume of
910 nm3 (911, 891, and 927 nm3, respectively), whereas the
volume of model 4 is 1027 nm3, a value 6.5s above the average
volume of the other models. This indicates that the TFIID
molecules contributing to model 4 enclose an additional mass.
The direct superposition of the models, however, was not
possible because of the complex structural transition experi-
enced by TFIID (Figure 2B). The 3D models were therefore split
into four subdomains that were consistently observed in order
to align the domains one with respect to the others and to
analyze the TFIID rearrangements more accurately (Figure 3A).
The A-lobes issued from models 1–3 have a similar beak-like
shape of 10.5 by 6 by 6 nm in size and occupy an average volume
332 nm3 (s = 3.2%), whereas in model 4 the A-lobe appears
slimmer and occupies a volume of 247 nm3 (Figure 3C). The
volume of the B-lobes was stable in all models (206 nm3, s =
5.6%) and their shape was also fairly similar except for model
2 in which it appeared split into two subdomains and thus
more elongated. Lobe C showed the largest variability in size
and shape and could be divided into two modules, C1 and C2,
whose relative orientations vary, suggesting that these modules
can move as independent entities. Whereas the C1- and C2-
lobes from models 1–3 were similar in size with an average
volume of 252 nm3 (s = 7.6%) and 118 nm3 (s = 14.2%), respec-
tively, these two lobes were larger in the case of model 4.
Although the size of lobe C1 showed a moderate increase of
49 nm3 (2.6 s above the average of models 1–3), the volume of
lobe C2 more than doubled with an increase of 158 nm3 (9.3 s
above the average of models 1–3).363–373, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 365
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Mapping Taf2p within TFIIDAltogether, these results indicate that model 4 comprises an
additional protein density in lobe C2. In order to better delineate
the additional density and to compensate for the flexibility of the
structure, the dissected lobes from model 3 were individually
positioned into model 4. This flexible domain docking revealed
two additional protuberances present only in model 4: a large
Figure 2. Structural Variants of TFIID
(A) Gallery of TFIID volumes obtained by electron tomography of negatively stained particles. The 28 represented volumes are averages obtained upon clustering
of a total of 157 aligned individual volumes. The six volumes that were most frequently used in the refinement are colored differently; those which were progres-
sively less used in the later refinement and discarded are in yellow whereas the four major variants are in red.
(B) Four major structural variants obtained upon analysis of an image dataset of frozen hydrated, negatively stained TFIID molecules. All four models show three
lobes (A, B, and C), and lobe C is separated into two domains (C1 and C2). The dashed lines represent the limits of each domain. The bars represent 10 nm.366 Structure 17, 363–373, March 11, 2009 ª2009 Elsevier Ltd All rights reserved
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Mapping Taf2p within TFIIDFigure 3. Comparison of the Obtained TFIID Models
(A) Dissection of TFIID model 3 into four subdomains: A, B, C1, and C2.
(B) Table showing the volume occupied by the different lobes A, B, C1 and C2. The average volume (Average) of a given lobe as well as the standard deviation (s)
are shown in the last rows. Note that for lobe C2 these values were calculated from models 1, 2, and 3 only. The columns labeled ‘‘D/s’’ represent the difference
between the volume of a lobe and the average volume of that lobe normalized by the associated standard deviation.
(C) Alignment of lobes A, B, and C dissected from all four TFIID models showing their structural homology.
(D) Fitting of TFIID model 3 into the envelope of the larger model 4 reveals two additional densities (highlighted by asterisks) in lobe C; red, blue, yellow, and brown
represent lobes B, C2, C1, and A, respectively. Bar indicates 2 nm, and model bottom was rotated 97 relative to top model.one in lobe C2 and a smaller one that connects lobe C1 to the A-
lobe (indicated by asterisks in Figure 3D).
In order to assess whether the structural heterogeneity found
in the TAP-A-TFIID preparation is related to the Taf2p depletion
detected by the biochemical data, we analyzed the relative
abundance of the four major TFIID populations within an image
dataset of the HA-TFIID preparation that contains a higher
Taf2p complement. Model 4, which represents 23% of the
TAP-A-TFIID preparation, increased to 55.2% in the HA-TFIID
preparation, indicating that the largest TFIID structure is more
abundant in the preparation that contains more Taf2p, thus
confirming that the additional protein domain found in model 4
reflects the presence of this subunit. Model 4 is thus the most
comprehensive TFIID structure and was therefore further refined
to reach the model shown in Figure 4, Figure S3, and Movie S1.
The resolution tests for this model calculated from 10,205
images gave values of 23 A˚ and 19 A˚ for the 0.5 Fourier shell
correlation and the half-bit criteria, respectively. Interestingly,
the size of the additional domain located between the C1 and
A lobes increased significantly upon refinement.
Antibody Labeling of Taf2p
To further confirm that the additional density in model 4 corre-
sponded to Taf2p, HA-TFIID was labeled with an antibody raised
against a peptide corresponding to residues 5–19 of Taf2pStructure 17, 3(Figure S4). The specific immune complexes formed upon incu-
bating the peptide affinity-purified antibodies with TFIID were
negatively stained and visualized by EM. A total of 1600 indi-
vidual TFIID immunoglobin G(IgG) images were selected and
aligned against references issued from model 4, which we
hypothesized contained the full length Taf2p. After image clus-
tering, the class-averages where the antibody was clearly bound
to TFIID were used to calculate a 3D map in which the position of
the antibody binding site could be determined by density differ-
ence with the unlabeled model 4 (Figure 5A). The bound antibody
highlighted the additional density present in the C2-lobe of
model 4, a result consistent with the hypothesis that this density
defines the Taf2p subunit of TFIID.
The peptide used to generate the antibody overlaps with the
first 6 residues of the leukotriene A4 hydrolase homology
domain. This homology extends over Taf2p residues 11–533,
and the entire conserved catalytic region defining the M1
protease family (residues 1–458 of leukotriene A4 hydrolase).
This region comprises structural domains A and B in the crystal
structure of the protease (Thunnissen et al., 2001). The homology
between Taf2p and leukotriene A4 hydrolase is substantial
because overall, 18% of the residues are identical for the two
domains. Moreover, the pattern of hydrophobic core residues
of the protease appears well conserved whereas the identity of
important residues in turns (predominantly Pro and Gly) and63–373, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 367
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Mapping Taf2p within TFIIDnumerous acidic and basic residues that form intramolecular salt
bridges in the crystal structure have also been conserved
between the two proteins (Figure 5B). Taken together, these
observations indicate that Taf2p is likely to adopt a ternary struc-
ture highly similar to the A and B domains of leukotriene A4
hydrolase. No significant homology exists between the
remainder of the Taf2p sequence and the additional domain in
the crystal structure, which is specific to the leukotriene A4
hydrolase subfamily of the M1 proteases. The docking of the
atomic structure indicated that the additional density revealed
in model 4 has a size large enough to accommodate the human
leukotriene A4 hydrolase domain (Figure 5C). Thus the slightly
Figure 4. Molecular Environment of Taf2p within TFIID
(A) Alignment of the previous TFIID volume (lower row; violet) with the higher
resolution model described in this report (upper row; yellow); the three lobes
of the structure A, B, and C are labeled.
(B) Localization of Taf2p relative to previously mapped Taf1p and TBP. (C)
Identification of a crescent-shaped TFIID subcomplex obtained upon removal
of the Taf1p, Taf2p, and TBP densities.368 Structure 17, 363–373, March 11, 2009 ª2009 Elsevier Ltd All rielongated and asymmetric shape of the domain fits within the
external contours of the C2 domain envelope, thereby providing
additional constraints for a precise positioning of the atomic
structure. Together these experiments indicate that the
N-terminal part of Taf2p is located in lobe C2 of TFIID.
Plasticity of the TFIID Structure
The comparison between the four TFIID models indicates that
with the exception of lobe C2, the domains are mostly conserved
in size and shape, but that the overall structure of TFIID is
variable. To further describe these TFIID domain movements,
each NS cryo-EM model was represented as a skeleton where
the center of each lobe is schematized by a disk, each con-
nected by a wire (Figure 6A). Angle a was defined as the angle
between lobes A, C1, and C2, and b as the angle between lobes
C1, C2, and B. The variation in a appears continuous within
a range of 60, from 53 (model 1) to 113 (model 4) (Figure 6B).
The angle b shows a smaller variation (23) and appears to adopt
two values: 120 in models 1 and 4 and 97 in models 2 and 3
(Figure 6C). This suggests that lobe B can adopt two discrete
conformations relative to lobe C. Another level of variability is
the rotation of lobes around their connections. In this respect,
lobes C2 and B show the highest flexibility because their relative
orientation was found to change by up to 73 between their posi-
tions in models 1 and 2. This contrasts with the fixed position of
lobe A relative to lobe C1. Collectively, these data argue that the
yTFIID complex is a flexible assembly that is likely capable of
adopting a number of distinct conformations.
DISCUSSION
The present cryo-EM study of frozen hydrated and negatively
stained yTFIID molecules provides the highest resolution map
available for this multiprotein transcription initiation factor and
stresses the importance of specimen heterogeneity in the quest
of finer details. Earlier attempts have previously shown that
conformational changes constitute a major limitation for reach-
ing high-resolution structural information (Grob et al., 2006).
Our results further emphasize the importance of variations in
subunit composition, which might, as in the case of Taf2p, affect
specimen homogeneity. Interestingly our new model not only
shows greater structural detail, but also converges toward the
structure of the hTFIID determined independently (Grob et al.,
2006) (Figure S5).
The structural characterization of molecular variations by EM
can be resolved by either experimental or computational
methods (Leschziner and Nogales, 2007). In all computational
approaches, a starting model is required either for alignment of
the particles or for angular assignment of the particle views for
3D reconstruction. The use of a starting model, however, might
bias the analysis, particularly if large structural fluctuations are
suspected, because alignment and/or angular assignment might
be incorrect for the most extreme conformations. In this report
specimen heterogeneity was addressed experimentally by
performing electron tomography to generate a 3D model for
each molecule without the need for any alignment or clustering
before 3D reconstruction. The drawbacks of using this method,
such as accumulated electron irradiation and a large missing
wedge of information, that result from the tilting experimentghts reserved
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Mapping Taf2p within TFIIDFigure 5. TFIID Immunolabeling with Taf2 Antibody
(A) Immunolabeling of TFIID by an antibody directed against the N terminus of Taf2p. The 3D model of TFIID is represented in yellow and the red surface repre-
sents the difference map between the antibody-labeled TFIID and the unlabeled complex.
(B) Alignment between leukotriene A4 hydrolase and human Taf2p. The conserved amino acids are highlighted.
(C) Docking of the atomic structure of the leukotriene A4 hydrolase domain that is homologous to the N-terminal part of Taf2p into the additional density present in
lobe C2 of model 4 shown in teal. The bars represent 2 nm; indicated in red is the additional density of the anti-Taf2p IgG.were overcome, to some extent, by respectively lowering the
electron dose and a posteriori averaging of molecular volumes.
Further progress in resolution will need to address any additional
structural and conformational fluctuations by biochemical
improvement of specimen homogeneity, or stabilization of
a particular conformation, by using more accurate tomographic
data collection from cryo samples to detect subtle intermolec-
ular variations and by developing computational methods to
separate heterogeneous image datasets.
Conformational Changes within yTFIID
The gallery of volumes resulting from the tomography experi-
ments showed extremely large movements of the major
domains. The conformational space explored by TFIID is consid-
erably reduced when the hydrated state of the molecules is
preserved and upon stabilization of a limited number of structural
states by the GraFix method. Nevertheless, the refinementStructure 17, 3process selected out four abundant states of TFIID and revealed
complex conformational transitions that are not limited to
a spring-like flexibility between the most extreme lobes but
involve significant reorganizations within domains. The four iden-
tified states could either represent stable conformations or
average snapshots of a continuous structural transition. Two
lines of evidence indicate that at least some transitions are
not completely continuous and that stable states might exist.
First, lobe B appears to adopt two discrete positions relative
to the rest of the structure (angle b in Figure 6), whereas
lobe C2 seems to adopt a continuous variation. Second, only one
of the four states showed an additional density suggesting
that the presence of Taf2p stabilizes a particular TFIID
conformation.
Whereas lobes A and B appeared most stable, lobe C was
found to undergo considerable conformational transitions. This
observation is consistent with previous work that analyzed63–373, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 369
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Mapping Taf2p within TFIIDconformational variations in hTFIID, where it was also noted that
the central domain is subject to reorganization (Grob et al.,
2006). The precise mechanism and the functional significance
of these conformational changes remain to be elucidated. The
possibility that the structure of TFIID can be adapted to allow
for the recognition of a large variety of promoters, each with
distinct activator binding site distributions, is particularly attrac-
tive. Along these lines, the recently reported structural change of
hTFIID upon incorporation of the cell-type specific Taf4b pa-
ralogue instead of Taf4p was correlated with modified promoter
selectivity (Liu et al., 2008). These observations suggest that the
precise conformation of the TFIID complex might contribute to
the specificity of promoter recognition. Alternatively, transcrip-
tion factor-TFIID interaction(s) might alter TFIID conformation
and directly modify promoter selectivity.
Figure 6. Flexibility of the TFIID Structure
(A) TFIID models 1, 2, 3, and 4 are represented as skeletons in which the
centers of the four major domains are symbolized by disks and the domain
connections by rods.
(B) Variations in the a angle between domains A, C1, and C2.
(C) Variations in the b angle between domains B, C2 and C1. The bars repre-
sent 2 nm.370 Structure 17, 363–373, March 11, 2009 ª2009 Elsevier Ltd All rigTaf2p Structure-Function Relationships
The localization of Taf2p was determined by taking advantage of
biochemical variation in Taf2p content and by immunolabeling.
Collectively these approaches showed that the N-terminal part
of Taf2p is located in the C-lobe. Moreover, this domain has
a size and a shape capable of accommodating the homologous
aminopeptidase fold. A second protein domain was also found
to be missing in those TFIID particles that do not contain the
N-terminal part of Taf2p. This domain connects lobes C to lobe
A and might correspond to the C-terminal part of Taf2p. Taken
together, these data suggest that the complete subunit is
missing from TFIID, and that the loss of Taf2p apparent by
SDS-PAGE analysis of TAP-tagged TFIID is most likely not due
to partial proteolytic cleavage.
In order to position Taf2p relative to the previously mapped
TFIID subunits (Leurent et al., 2002; Leurent et al., 2004), our
former 32 A˚ resolution model was aligned against the present
23 A˚ resolution model and an unambiguous superposition could
be obtained (Figure 4A). Our results indicate that the C-terminal
part of Taf2p maps close to TBP, a TFIID subunit that interacts
with the N-terminus of Taf1p with high affinity (Bai et al., 1997;
Banik et al., 2001; Verrijzer et al., 1994) (Figure 4B). This prox-
imity is consistent with earlier data showing a direct interaction
among these three proteins forming a stable subcomplex
capable of binding promoter DNA in vitro (Chalkley and Verrijzer,
1999). Although the existence of such a subcomplex has yet to
be demonstrated in vivo, the finding that in the P. falciparum
genome homologs of Taf1p, Taf2p, and TBP, but of no other
Tafs (with the possible exception of Taf10p), could be identified,
strengthens the functional significance of a Taf1p-Taf2p-TBP
subcomplex (Callebaut et al., 2005). Within TFIID, this ternary
complex is likely to be extended and to encompass both lobes
A and C because the largest C-terminal part of Taf1p was found
to be located in lobe A where it could contact the C-terminal part
of Taf2p, whereas the N-terminal end of Taf1p reached toward
lobe C where the N-terminal part of Taf2p was mapped (Leurent
et al., 2004). TBP was also found to be located between the A
and C lobes. In this respect it is notable that a C-terminal 369
amino acid fragment of Drosophila Taf2p was reported to bind
directly and independently to both TBP and Taf1p (Verrijzer
et al., 1994). The major contacts between these polypeptides
are thus likely to occur through the C-terminal portion of Taf2p,
which we speculate corresponds to the protein density located
between lobes A and C.
The extended DNA binding profile of TFIID compared with TBP
can be partially mimicked by the Taf1p-Taf2p-TBP ternary
complex, suggesting that this subcomplex contains many of
the DNA binding properties of TFIID (Verrijzer et al., 1995;
Verrijzer et al., 1994). Taf2p by itself was reported to interact
with the initiator core promoter element (Inr) (Kaufmann et al.,
1996; Verrijzer et al., 1995; Verrijzer et al., 1994) and in the
context of hTFIID, Taf2p could be crosslinked to the Adenovirus
Major Late Promoter Inr element (Oelgeschlager et al., 1996).
Taken together, these results indicate that Taf2p is likely to
participate in start-site selection on certain promoters through
its ability to bind the Inr. The relative positions of TBP and
Taf2p in our TFIID model thus suggest an orientation of the
promoter DNA: the upstream region should contact TBP
whereas the transcription initiation site of the promoter wouldhts reserved
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Mapping Taf2p within TFIIDbe positioned closer to the Taf2p region. The TBP-Taf2p location
further defines a curved DNA binding interface that, according to
our model, can be as large as 15 nm and could thus accommo-
date up to 45 bp promoter DNA within the clamp. It is tempting to
speculate that this distance is related to the downstream DNase I
hypersensitive sites which were detected on several yeast
promoters at 45 bp downstream of the TATA box (Sanders
et al., 2002), but additional experiments are required to address
this question. Finally, the proposed location for the promoter
DNA within the clamp formed by TFIID gives strong spatial
constraints for the assembly of the preinitiation complex. The
volume forming the clamp is large enough to contain a sphere
with a diameter of 12.5 nm and could thus accommodate several
transcription proteins.
Identification of a TFIID Core Subcomplex
Several lines of evidence indicate that the 3D architecture of
TFIID is likely to contain a stable core subcomplex onto which
an independent module is assembled. The use of RNAi to probe
the stability of the TFIID complex in Drosophila tissue culture
cells revealed the existence of a stable core-TFIID subcomplex
composed of Taf5p and the two histone fold domain (HFD)-
containing Taf pairs Taf4p/12p and Taf6p/9p (Wright et al.,
2006). This core-TFIID is believed to be decorated with periph-
eral subunits, in particular those that compose the Taf1p-
Taf2p-TBP subcomplex. Additional results consistent with these
observations had previously been reported during biochemical
analyses of TFIID purified from yeast expressing a tempera-
ture-conditional mutated form of Taf1p (Singh et al., 2004). In
order to translate these observations onto our EM map, the
potential protein densities of Taf1p, Taf2p, and TBP were
removed from the TFIID envelope. The shape of the remaining
structure is reminiscent of that of a stable in vitro reconstituted
complex composed of Taf5p and the three HFD pairs Taf4p/
12p, Taf6p/9p, and Taf8p/10p (Leurent et al., 2004), and interest-
ingly presents an almost symmetric crescent-shaped structure
(Figure 4C). Consistent with this observation are the biochemical
quantization and in vivo self-association properties of yeast Tafs,
which showed that several polypeptides are present with more
than one copy in each TFIID molecule (Sanders et al., 2002).
These results were confirmed by immuno-EM data that showed
that at least Taf5p and the five HFD-containing subunits (Taf10p,
Taf6p/9p, Taf4p/12p) are present as two copies (Leurent et al.,
2002). The Tafs present as two copies are likely to form a two-
fold symmetric assembly similar to the subcomplex outlined
within TFIID. Altogether, the higher resolution structure and the
immunolabeling studies strongly suggest that TFIID is
composed of two subcomplexes. On one hand, a core complex
containing Taf5p and most of the HFD-containing Taf-pairs
(Taf6p/9p, Taf4p/12p, Taf8p/10p, Taf11p/13p) is proposed to
adopt a crescent-shaped two-fold symmetric structure. On the
other hand, a complex containing Taf1p, Taf2p and TBP, as
well as probably Taf7p, is predicted to be recruited to this core
complex.
In summary, we have mapped the location of the Taf2p subunit
within the yTFIID holocomplex. Further, by capitalizing on the
substoichiometric Taf2p content of certain preparations of TFIID,
complemented by single-particle tomography, immunolabeling,
and cryo-EM, we have generated a 23 A˚ model of yTFIID. ThisStructure 17, 3new model has both higher structural resolution as well as
increased definition of the location of the three TFIID subunits
(Taf1p, Taf2p, and TBP) that likely participate critically in both
promoter binding and promoter selectivity. Additional experi-
mentation designed to provide further details of yTFIID structure,
both alone and complexed with other GTFs, promoter DNA, and
transactivator proteins are in progress. This work will provide
additional insights into how TFIID subserves both its coactivator
and promoter recognition functions.
EXPERIMENTAL PROCEDURES
TFIID Purification
HA1-Taf1p-tagged TFIID was purified from S. cerevisiae strain YSLS18 as
described previously (Sanders et al., 2002; Sanders and Weil, 2000); note
that this purification scheme utilized ethidium bromide to prevent TFIID-
DNA interactions during purification. TAP-Taf1p-tagged TFIID was purified
from yeast strain YLSTAF1 (kindly provided by Dr. Ray Jacobson, University
of Texas MD Anderson Cancer Center). This strain expresses Taf1p with
4.5 copies of the TAP tag (protein A4.5X-TEV protease site-calmodulin binding
domain; Tasto et al., 2001) at the C terminus. YLSTAF1 cells were grown to
mid-log phase, harvested, and processed for TFIID purification as for
YSLS18. An overview of the three steps used for the subsequent purification
of TFIID are as follows: (a) solubilized TAP-Taf1p TFIID was bound to IgG
Sepharose and eluted using the TEV protease, (b) the IgG Sepharose eluate
was bound to calmodulin (CaM)-Sepharose and eluted with EGTA, (c) the
CaM-Sepharose eluates were immediately loaded onto a Mono-S FPLC
column, the column washed, and TFIID eluted with a gradient of 1 M salt.
The TAP-tagged TFIID prepared by this procedure is highly concentrated
(1–3 mg/ml), and the typical yield is 3–3.5 mg TFIID/kg cells. Neither prepara-
tion generated TFIID with significant amounts of either contaminating DNA or
RNA (Figure S5).
Anti-Taf2p Peptide Antibodies
Rabbit antibodies against Taf2p N-terminal amino acid residues 5–19 (SKNAT-
PRAIVSESST) were prepared by Antagene Inc (Mountain View, CA). Peptide
immobilized on Sulfolink beads (Pierce, Inc.) with an added C-terminal
cysteine residue was used for affinity purification of antibodies specifically
recognizing Taf2p N-terminal sequences. These antibodies only recognized
the Taf2p subunit of TFIID (Figure S6).
Electron Tomography
Single tilt tomography was performed at room temperature using an FEI
Tecnai F20 electron microscope operating at 200 kV. Specimens were
observed under low-dose conditions (total dose of 40–50 e/A˚2) with a tilt
range of 65 to +65 degrees. Specimens were sandwiched between two
layers of carbon using 2% uranyl-acetate as a stain and 0.1% glutaraldehyde
as a cross-linking agent. The tomograms were reconstructed using the IMOD
software package (Kremer et al., 1996). To investigate the differences
between the 3D models, the maps were first roughly aligned in real space
using Chimera’s ‘‘fit map in map’’ tool (Pettersen et al., 2004). This prealign-
ment was refined by cross correlation and the aligned volumes were
clustered after multivariate statistical analysis using the IMAGIC software
package (van Heel et al., 1996).
Single-Particle Cryo-Electron Microscopy
The yTFIID sample was prepared using the GraFix method (Kastner et al.,
2008) in a buffer containing 10 mM Tris-HCl (pH 8.0), 300 mM NaCl, and
according to the cryonegative stain method (Golas et al., 2005). Images
were collected at liquid nitrogen temperature under low-dose condition
(15–20 e/A˚2), at a magnification of 40,0003 on Kodak SO-163 films. The defo-
cus values ranged from 0.137 to 1.96 mm. Micrographs with no visible drift
were digitized with a 5 mm raster size using a drum scanner (Primescan
D7100, Heidelberg) and coarsened twice to obtain a final pixel spacing of
0.254 nm. Boxing and CTF phase flipping of the 44,233 TFIID images were
performed in the EMAN software package. The image processing was63–373, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 371
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Mapping Taf2p within TFIIDperformed using the IMAGIC (Image Science Software, Berlin, Germany) and
Spider (Frank et al., 1996) software packages as described earlier. The resolu-
tions of the final reconstructions were estimated according to the 0.5 cut-off in
the Fourier shell correlation curve (0.5 FSC criterion) and the intersection point
of the half bit curve with the FSC curve (half bit criterion) (van Heel and Schatz,
2005). The final reconstructions were filtered to the measured resolution.
Immuno-Electron Microscopy
For immuno-EM, a 3- to 5-fold molar excess of anti-Taf2p IgG was incubated
30 min at 20C with purified HA-tagged TFIID at a final protein concentration of
30 mg/ml. Images of TFIID molecules putatively labeled by the IgG were
collected and aligned against projections of model 4 (see Figure 3B). The
aligned images were then analyzed by using multivariate statistical methods
and hierarchic ascendant classification. Class average images were selected
where the antibody bound to TFIID was clearly recognized and a 3D map of the
complex was determined to position the antibody binding site. The obtained
volume along model 4 was normalized and a difference map was created by
subtracting model 4.
ACCESSION NUMBERS
The density map of the yTFIID has been deposited at the Macromolecular
Structure Database under accession number EMD-5026.
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